April 25, 2025 a 08:00 am

JNJ: Fundamental Ratio Analysis - Johnson & Johnson

Johnson & Johnson Stock Overview

Johnson & Johnson shows a stable financial performance with diversified healthcare products spanning pharmaceuticals, consumer health, and medtech. Despite challenges in the broader market, its fundamentals depict resilience and potential for steady growth.

Fundamental Rating

Johnson & Johnson presents a strong overall rating with key strengths in return metrics despite some concerns in its valuation ratios.

Category Score Visualization
Discounted Cash Flow 4
Return on Equity 5
Return on Assets 5
Debt to Equity 2
Price to Earnings 1
Price to Book 1

Historical Rating

Comparison of current and past ratings shows consistent performance with little variation in critical scores.

Date Overall Score DCF ROE ROA D/E P/E P/B
2025-04-24 3 4 5 5 2 1 1
Previous 0 4 5 5 2 1 1

Analyst Price Targets

Analyst consensus suggests a stable price target range with limited downside risk.

High Low Median Consensus
166 162 164 164
JNJ Stock Price Chart

Analyst Sentiment

The sentiment from analysts remains positive, with a predominant number of buy recommendations.

Recommendation Count Distribution
Strong Buy 0
Buy 17
Hold 14
Sell 3
Strong Sell 0

Conclusion

Johnson & Johnson remains a resilient entity within the healthcare sector, with strong fundamentals and a diverse product portfolio. The company faces some valuation challenges but maintains solid return metrics, making it an attractive option for long-term investment. Analysts remain optimistic, highlighting potential stable growth with moderate risk factors. Overall, JNJ looks well-poised to navigate future market dynamics with steady performance.

This HTML snippet is designed to be easily embedded into a webpage and optimized for mobile viewing with headers, structured content, and responsive images while avoiding inline CSS except for the score-bar div components.